Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 22 - Number 12


Review Article (Mini-Review)

Antibiotic Adjuvants: A Promising Approach to Combat Multidrug Resistant Bacteria

, 22(12): 1334 - 1345

Namita Sharma, Anil K. Chhillar*, Sweety Dahiya, Pooja Choudhary, Aruna Punia and Prity Gulia


DOI: 10.2174/1389450122666210120084406



Review Article (Mini-Review)

Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance

, 22(12): 1346 - 1356

Dinesh S. Moirangthem and Laishram Surbala*


DOI: 10.2174/1389450121999201202110303



Review Article (Mini-Review)

Potential Role of In Vitro-In Vivo Correlations (IVIVC) for the Development of Plant-Derived Anticancer Drugs

, 22(12): 1357 - 1375

Mohamed S.T.A. Azeeze*, Shanthi B. Santhosh, Murugesan S. Manjari and Subramania N. Meyyanathan


DOI: 10.2174/1389450121999201113110433



Review Article

Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease

, 22(12): 1376 - 1403

Suvadeep Mal, Udita Malik, Dilipkumar Pal* and Abhishek Mishra


DOI: 10.2174/1389450121999201230203709



Review Article

Recent Advances in Nanotechnology-Based Drug Delivery Approaches for Alzheimer disease

, 22(12): 1404 - 1423

Ishnoor Kaur, Arun Kumar*, Tapan Behl and Dhruv Setia


DOI: 10.2174/1389450122999210104205018



Review Article

Novel Strategies to Combat the Emerging Drug Resistance in Human Pathogenic Microbes

, 22(12): 1424 - 1436

Hafsa Qadri, Abdul H. Shah* and Manzoor Mir*


DOI: 10.2174/1389450121666201228123212



Review Article

Recent Advances in the Discovery of GSK-3 Inhibitors from Synthetic Origin in the Treatment of Neurological Disorders

, 22(12): 1437 - 1462

Supriyo Saha*, Dilipkumar Pal and Satish B. Nimse


DOI: 10.2174/1389450122666210120143953




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Advertisement

Dec-2021-ban

Related Journals

Related eBooks

eBooks Catalog